Opportunity

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials 3443683

  • Procurement and Logistics Service
  • Belfast Health and Social Care Trust
  • Western Health and Social Care Trust

F02: Contract notice

Notice reference: 2021/S 000-007847

Published 14 April 2021, 4:55pm



Section one: Contracting authority

one.1) Name and addresses

Procurement and Logistics Service

Supplies Centre, Gransha Hospital

Londonderry

BT47 6YZ

Email

jayne.keatley@hscni.net

Country

United Kingdom

NUTS code

UK - UNITED KINGDOM

Internet address(es)

Main address

https://etendersni.gov.uk/epps

Buyer's address

https://etendersni.gov.uk/epps

one.1) Name and addresses

Belfast Health and Social Care Trust

A Floor, Belfast City Hospital, Lisburn Road

Belfast

BT9 7AB

Email

jayne.keatley@hscni.net

Country

United Kingdom

NUTS code

UK - UNITED KINGDOM

Internet address(es)

Main address

https://etendersni.gov.uk/epps

Buyer's address

https://etendersni.gov.uk/epps

one.1) Name and addresses

Western Health and Social Care Trust

Altnagelvin Area Hospital, Glenshane Road

Londonderry

BT47 6SB

Email

jayne.keatley@hscni.net

Country

United Kingdom

NUTS code

UK - UNITED KINGDOM

Internet address(es)

Main address

https://etendersni.gov.uk/epps

Buyer's address

https://etendersni.gov.uk/epps

one.2) Information about joint procurement

The contract involves joint procurement

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://etendersni.gov.uk/epps

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

https://etendersni.gov.uk/epps

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials 3443683

two.1.2) Main CPV code

  • 33000000 - Medical equipments, pharmaceuticals and personal care products

two.1.3) Type of contract

Supplies

two.1.4) Short description

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.1.5) Estimated total value

Value excluding VAT: £11,607,952

two.1.6) Information about lots

This contract is divided into lots: Yes

Tenders may be submitted for maximum number of lots
32

two.2) Description

two.2.1) Title

Lot 1: Ioflupane I-123

Lot No

1

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £2,336,340

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The

Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and

including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 2: MIBG I-123 (metaiodobenzylguanidine)

Lot No

2

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £156,576

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 3: Sodium Iodide I-123

Lot No

3

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £89,803

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 4: Sodium Iodide Therapy Capsule I-131

Lot No

4

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £254,872

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 5: Sodium Iodide Liquid I-131

Lot No

5

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £1,252

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 6: Therapeutic MIBG I-131 (metaiodobenzylguanidine)

Lot No

6

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £99,613

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 7: Gallium Citrate Ga-67

Lot No

7

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £1,788

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 8: Generator Krypton Gas Kr-81

Lot No

8

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £262,800

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 9: Generator Technetium Mo-99/Tc-99m

Lot No

9

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £1,283,128

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 10: Samarium Sm-153

Lot No

10

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £14,800

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 11: Selenium Homocholic Acid Taurine/Tauroselcholic Acid Se-75

Lot No

11

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £448,380

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 12: Radium Dichloride Ra-223

Lot No

12

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £786,480

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 13: Indium DTPA In-111 (Diethylenetriamine Pentaacetate)

Lot No

13

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £1,480

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 14: OCTREOSCAN 122MBQ IN111 (OCTREOTIDE)

Lot No

14

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £260,640

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 15: DMSA (Dimercaptosuccinic Acid)

Lot No

15

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £29,872

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1

two.2) Description

two.2.1) Title

Lot 16: DTPA (Diethylenetriamine Pentaacetate)

Lot No

16

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £12,132

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1

two.2) Description

two.2.1) Title

Lot 17: Exametazime

Lot No

17

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £82,200

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 18: HDP (Hydroxymethylene Diphosphonate)

Lot No

18

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £51,040

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 19: Human Albumin Nanocolloid

Lot No

19

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £91,900

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 20: MAA (Macro Aggregated Albumin)

Lot No

20

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £49,432

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 21: Mertiatide

Lot No

21

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £90,640

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 22: Mebrofenin

Lot No

22

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £6,120

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 23: MIBI (Sestamibi - Methoxyisobutylisonitrile)

Lot No

23

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £147,062

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 24: Sodium Pyrophosphate

Lot No

24

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £1,672

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 25: Tetrofosmin

Lot No

25

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £139,280

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 26: Tin Colloid

Lot No

26

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £460

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

LOT 27 – Tektrotyd

Lot No

27

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £287,250

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

LOT 28 - Diphosphono-Propanedicarbosylic Acid (DPD)

Lot No

28

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £2,480

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

LOT 29 - Sirspheres

Lot No

29

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £92,654

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

LOT 30 - Lutathera

Lot No

30

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £4,450,800

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

Lot 31- Yttrium Silicate Y-90

Lot No

31

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £19,437

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

two.2) Description

two.2.1) Title

LOT 32 - Sterile Nitrogen Vials

Lot No

32

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33151400 - Radiotherapy supplies

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

two.2.5) Award criteria

Price

two.2.6) Estimated value

Value excluding VAT: £55,584

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

It is anticipated that this Framework Agreement will commence on 7th September 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.


Section three. Legal, economic, financial and technical information

three.1) Conditions for participation

three.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

three.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement

Framework agreement with several operators

Envisaged maximum number of participants to the framework agreement: 3

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.2) Time limit for receipt of tenders or requests to participate

Date

18 May 2021

Local time

3:00pm

four.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.6) Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until: 15 October 2021

four.2.7) Conditions for opening of tenders

Date

18 May 2021

Local time

3:30pm


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.4) Procedures for review

six.4.1) Review body

Business Services Organisation, PaLS

77 Boucher Crescent

Belfast

BT12 6HU

Country

United Kingdom